BUILDING LEASE DEFINITIONS AND CERTAIN BASIC PROVISIONSBuilding Lease • January 6th, 2011 • Arkson Neutraceuticals Corp. • Blank checks
This Article 3 is subject to any contrary requirements under applicable law; however, by entering this lease agreement, Tenant admits and agrees that Tenant was granted ample time and opportunity to inspect the Demised Premises and to have qualified experts inspect the Demised Premises prior to the execution of this Lease. Tenant agrees to and does hereby accept the Demised Premises, including all improvements located on the Demised Premises, "AS IS" and "WHERE IS", "WITH ALL FAULTS", with Tenant accepting all defects, if any; and Landlord makes no warranty of any kind, express or implied, with respect to the Demised Premises including the Build-Out of the Demised Premises, further, and without limitation, Landlord makes no warranty as to the habitability, fitness or suitability of the Demised Premises (including any Build-Out of the Demised Premises) for a particular purpose nor as to the absence of any toxic or otherwise hazardous substances. Also, Tenant acknowledges and agrees that
NON-COMPETITION, NON-DISCLOSURE, AND NON-SOLICITATION AGREEMENTNon-Competition, Non-Disclosure, and Non-Solicitation Agreement • January 6th, 2011 • Arkson Neutraceuticals Corp. • Blank checks • Texas
This Non-Competition, Non-Disclosure and Non-Solicitation Agreement (“Agreement”), dated this _______ day of December 2010 (the “Effective Date”), by and between ___________________________________ (“Holder”) and Piper Acquisition III, Inc., a Nevada corporation (the “Purchaser”).
LOCK-UP AGREEMENTLock-Up Agreement • January 6th, 2011 • Arkson Neutraceuticals Corp. • Blank checks • Nevada
THIS LOCK-UP AGREEMENT (this “Agreement”) is made and entered into as of December ___, 2010, by and among Piper Acquisition III, Inc., a Nevada corporation (the "Company") and _________ (the “Holder”), including the Holder’s successors and permitted assigns.
AGREEMENT AND RELEASERelease Agreement • January 6th, 2011 • Arkson Neutraceuticals Corp. • Blank checks • New York
This Agreement (the “Agreement”) is dated December 31, 2010 and is made by and between Arkson Neutraceuticals Corp. (the “Company” or “Arkson”), on one hand, and David Roff (“Shareholder”), on the other hand.
VOTING AGREEMENTVoting Agreement • January 6th, 2011 • Arkson Neutraceuticals Corp. • Blank checks • Texas
Agreement made as of this 31st day of December, 2010, by and among (i) Piper Acquisition III, Inc., a Nevada Corporation (the "Company"), (ii) the stockholders named on Schedule I hereto, (the "Stockholders" and singularly as a "Stockholder") and (iii) Jacob Varon and Tony Rotondo (collectively, the "Principals").
